Trial site
Chuo Ku
- 20running trials
- 14closed trials
The trials here
What the 34 trials at this site are about, from their registry records.
- Conditions
- Lung cancer10 trials
- Colorectal cancer5 trials
- Childhood cancers4 trials
- High blood pressure4 trials
- Melanoma4 trials
- Prostate cancer4 trials
- Lupus (SLE)3 trials
- Sjögren's disease3 trials
- Triple-negative breast cancer3 trials
- Aplastic anaemia2 trials
- Coronary artery disease2 trials
- Head and neck cancer2 trials
- and 16 more
- Phase
- Phase 312 trials
- Phase 18 trials
- Phase 26 trials
- Phase 1/22 trials
- Phase 41 trial
- Status
- Completed11 trials
- Active, not recruiting10 trials
- Recruiting10 trials
- Terminated3 trials
- Lead sponsor
- Novartis Pharmaceuticals34 trials
Running trials
Recruiting
Active, not recruiting
Recruiting
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
Recruiting
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Recruiting
Active, not recruiting
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors
Active, not recruiting
Active, not recruiting
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Prostate cancer3 recruiting
- Childhood cancers2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Aplastic anaemia1 recruiting
- Colorectal cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- High blood pressure1 recruiting
- Lupus (SLE)1 recruiting
- Metastatic breast cancer1 recruiting
- Neuroendocrine tumours1 recruiting
- Pancreatic cancer1 recruiting
- Sarcoma1 recruiting
- Thyroid cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Study of Efficacy and Safety of Canakinumab in Japanese Patients With AOSD
Completed
Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome
Completed
Completed
Terminated
Safety and Preliminary Efficacy of JBH492 Monotherapy in Patients With CLL and NHL
Terminated
A Phase I/Ib Study of NIZ985 Alone and in Combination With Spartalizumab
Completed
Terminated
Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies
Completed
Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients
Recruiting
Site data: ClinicalTrials.govUpdated 17 Nov 2026